Dose-dependent decrease in hepatitis delta virus (HDV) RNA...

Journal of Clinical Virology 2015 / 08 Vol. 69

Dose-dependent decrease in hepatitis delta virus (HDV) RNA achieved with the oral prenylation inhibitor lonafarnib in a proof-of-concept, randomised, double-blinded, placebo-controlled study in patients with chronic HDV infection

Koh, C., Canini, L., Dahari, H., Cooper, S., Cory, D., Winters, M.A., Choong, I., Cotler, S.J., Kleiner, D.E., Yurdaydin, C., Heller, T., Glenn, J.S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Language:
english
Journal:
Journal of Clinical Virology
DOI:
10.1016/j.jcv.2015.06.071
Date:
August, 2015
File:
PDF, 98 KB
english, 2015
Conversion to is in progress
Conversion to is failed